Antibacterial activity of some chemical constituents from Trichilia prieuriana (Meliaceae)
-
Julio Issah Mawouma Pagna
Abstract
The chemical study of hydroethanolic extracts from different parts of Trichilia prieuriana (Meliaceae) led to the isolation and identification of 22 compounds: 2β,3β,4β-trihydroxypregnan-16-one (1), prieurianin (2), flindissone (3), deoxyflindissone (4), picraquassin E (5), ursolic acid (6), 3β-acetoxy-11α-hydroxyurs-12-en (7), 3β-acetoxy-urs-12-en-11-one (8), 3β-acetoxy-β-amyrin (9), friedelin-3-ol (10), 3-oxo, friedelin (11), 3-oxo, fridelin-28-ol (12), oleanolic acid (13), hederagenin (14), mixture of stigmasterol (15), β-sitosterol (16), β-sitosterol-3-O-β-glucopyranoside (17) and stigmasterol-3-O-β-glucopyranoside (18), erythrodiol (19), scopoletin (20), 4-hydroxy-3,5-dimethoxybenzoic acid (21) and shikimic acid (22). The absolute configurations and crystal structures of compounds 1 and 2 are reported herein for the first time. Crude extracts, fractions and isolated compounds were evaluated for their antibacterial activities against nine bacterial strains. Crude extracts from the root wood of T. prieuriana exhibited good antibacterial potency with minimal inhibitory concentration (MIC) values ranging from 31.25 to 500 µg mL−1 on the test bacteria. The ethyl acetate fraction from root wood and n-hexane-ethyl acetate (3:1) fraction from leaves showed a moderate antibacterial activity with MIC value of 250 μg mL−1 on all test bacteria. Isolated compounds exhibited significant antibacterial activity with MIC values ranging from 4.09 to 71.8 µm. Compounds 3, 6 and 7 were the most active with a broad spectrum of activities.
1 Introduction
The real implications of spreading drug resistance are being felt worldwide, with developing countries and large emerging nations bearing the brunt of this problem. Routine surgeries and minor infections are becoming life-threatening once again and the hard-won victories against infectious diseases of the last 50 years is facing jeopardy. Drug-resistant infections are on the rise with estimates of over 700,000 lives lost each year due to antibiotic-resistant infections caused by illnesses such as bacterial infections, malaria, HIV/AIDS or tuberculosis. Of particular note, resistance against nearly all antibiotics used clinically have been documented in bacteria. This has led to emergence of such bacterial infections which are essentially untreatable by the current armamentarium of available treatment options [1]. Various efforts have been made to develop the newer antimicrobials with novel modes of action which can act against these multi-drug resistant strains. The deployed strategies include the investigation of natural products from ethnopharmacologically relevant medicinal plants to unveil novel chemical scaffolds with promising antibacterial potency. Within this framework, the genus Trichilia (Meliaceae) that comprises some 90 species of shrubs and trees mainly distributed across the tropical and subtropical regions of the world is of particular interest [2]. Plants of Trichilia genus are widely used in folk medicine to treat various ailments including microbial infections and parasitic diseases [3]. Trichilia prieuriana Juss finds uses in indigenous medicine for the treatment of malaria, trypanosomiasis, syphilis, pneumonia and colds. The decoctions and/or infusions of T. prieuriana prepared in water have been used for many years to treat various bacterial infections [4]. The genus Trichilia has attracted our attention in recent years as an important natural source of bioactive limonoids which are valuable for the taxonomic evaluation of this genus [5]. The diverse ethnobotanical uses of Trichilia plants have impelled us to thoroughly investigate their chemical constituents, which led to the isolation and identification of a prodigious array of bioactive natural products mainly limonoids [6], sesquiterpenes [7], triterpenoids [8], and steroids [9]. Additionally, extracts, fractions and isolated compounds from plants of Trichilia genus have a wide range of biological activities including anti-inflammatory, antioxidant, antimalarial, cytotoxic, hepatoprotective, antiviral, antifungal and antibacterial activities [8, 10, 11].
In continuation of our research on the bioactive secondary metabolites with structural and biological diversity from Trichilia species collected in Cameroon [6, 10, 11], we investigated the hydroethanolic extracts from root wood, root bark, stem bark and leaves of T. prieuriana with respect to its chemistry, pharmacology and antibacterial activity. Herein, we report the isolation, identification, antibacterial activities of extracts and isolated compounds, as well as the absolute configurations and crystal structures of compounds 1 and 2.
2 Results and discussion
2.1 Isolation and identification of compounds
Twenty-two (22) compounds were isolated through the bio-guided fractionation of the hydro-ethanolic extracts from different parts of T. prieuriana by usual chromatographic techniques. Their structures were established by spectroscopic methods and by comparison to data of related compounds described in the literature, while the molecular structures of compounds 1 and 2 were confirmed by single-crystal X-ray (SC-XRD) diffraction analyses.
Compound 1 was isolated as colourless crystals from the n-hexane-EtOAc (3:2) fraction of the root wood of T. Prieuriana. It gave a red colour in the Liebermann-Burchard reaction suggesting its steroidic character. Its molecular formula, C21H34O4 (five degrees of unsaturation) was deduced from its HR-ESI-MS spectrum (positive mode), where sodium adduct ion peak was observed at m/z = 373.2395 [M + Na]+ (calcd. 373.2349 for C21H34O4Na). Its IR spectrum exhibited vibration bands at 3324 and 1735 cm−1 due to the hydroxyl and five-membered ring ketone, respectively. The 1H NMR data (Table S1) showed resonance due to one methyl triplet at δ = 1.02 ppm (3H, t, J = 12 Hz), two methyl singlets at δ = 0.70 ppm (3H, s) and δ H = 1.26 ppm (3H, s), and three oxymethine protons at δ = 4.14 (H, brd) 3.53 (H, brd) and 3.84 ppm (H, brd). The 13C NMR spectrum showed resonances signals which were sorted into three methyl groups (CH3) at δ = 13.5; 13.7 and 17.4 ppm; seven (07) methylene groups (CH2) all sp 3-hybridized at δ = 17.2; 20.2; 18.3; 32.5; 38.2; 38.6 and 43.2 ppm; eight (08) methine groups (CH) all sp 3-hybridized at δ = 34.1; 50.5; 50.6; 56.8 and 65.2 ppm among which three (03) oxymethine groups (CH–OH) at δ = 71.8, 72,3 and 76.7 ppm and one keto carbonyl group at δ = 219.5 ppm. The above structural features together with correlations from 1H-1H COSY, HSQC and HMBC experiments suggested that compound 1 is 2β,3β,4β-trihydroxypregnan-16-one [12] (see Figure 1).

Chemical structures of compounds 1–22 isolated from Trichilia prieuriana.
Compound 2 was isolated as colourless crystals from the n-hexane-EtOAc (3:2) fraction of the stem bark of T. Prieuriana. It gave a red colour in the Liebermann–Burchard reaction and a pink colour in the Ehrlich test, suggesting its limonoïdic nature. Its molecular formula, C38H50O16 (14° of unsaturation) was deduced from its HR-ESI-MS spectrum (positive mode). The ion peak of the sodium adduct was observed at m/z = 785.3004 [M + Na]+ (calcd. 785.2991 for C38H50O16Na). Its IR spectrum showed maximum absorption bands at 3067 and 1740 cm−1 characteristic of hydroxyl and carbonyl groups, respectively. Based on the HR-ESI-MS, 1H NMR and 13C NMR data (Table S2), X-ray crystallographic data (see below) and by spectral comparison with previous reported values, compound 2 was elucidated to be prieurianin [13] (see Figure 1).
Confirmation of the molecular structures and the absolute stereochemistry of compounds 1 and 2 were obtained by SC-XRD analysis (see below).
The 20 other compounds (3–22) were identified as: flindissone (3) [14], deoxyflindissone (4) [15], picraquassin E (5) [16], ursolic acid (6) [17], 3β-acetoxy-11α-hydroxyurs-12-en (7) [18], 3β-acetoxy-urs-12-en-11-one (8) [19], 3β-acetoxy-β-amyrin (9) [20], friedelin-3-ol (10) [21], 3-oxo, friedelin (11) [22], 3oxo, fridelin-28-ol (12) [23], oleanolic acid (13) [24] hederagenin (14) [25], stigmasterol (15) [26], β-sitosterol (16) [26] and their glycosylated derivatives β-sitosterol-3-O-β-glucopyranoside (17) [27] and stigmasterol-3-O-β-glucopyranoside (18) [27], erythrodiol (19) [28], scopoletin (20) [29], 4-hydroxy-3,5-dimethoxybenzoic acid (21) [30] shikimic acid (22) [31] (see Figure 1). The NMR data of compounds 1 and 2 are given in the Supporting Information available online.
2.2 X-ray crystal structure determinations
The crystallization of compounds 1 and 2 from MeOH and a mixture of acetone-CH2Cl2-MeOH (0.5:1:1), respectively, provided colourless crystals. The successful refinement of the Flack x parameters (see Section 3) allowed the determination of the absolute structures of 1 and 2 as they are depicted in Figures 1 and 2.

Ortep drawing of the molecular structures of compounds 1 and 2 in the crystal. Only the asymmetric carbon atoms were labelled. Displacement ellipsoids were drawn at the 50% probability level.
Compound 1 shows 10 asymmetric carbon atoms which turned out to be C3 S; C4 S; C7 R; C8 R; C9 S; C10 S; C12 R; C13 S; C16 S and C17 R (Figure 2a shows atom labels). In compound 2, the chirality of the twelve stereo-centres could be determined as follows: C3 is S; C4 R; C5 R; C6 S; C7 R; C8 R; C9 R; C10 R, C11 S; C14 S; C29 R and C30, R (Figure 2b shows atom labels).
2.3 Antibacterial potential of extracts, fractions and compounds
The antibacterial activity of extracts, fractions and compounds (1–22) was evaluated against nine pathogenic bacteria strains using the micro broth dilution method [32] The nine test bacterial strains were Staphylococcus aureus CHU, Shigella flexneri NR 518, Klebsiella pneumoniae ATCC 700603, Escherichia coli ATCC 25922, Salmonella enterica anatum, S. aureus BAA 917, S. aureus ATCC 43300, E. coli CHU and Streptococcus pneumoniae ATCC 49619. The tested crude extracts, fractions and compounds exhibited varied levels of antibacterial activities against the test bacteria as shown in Table S3. From the results, the MIC values of crude extracts ranged from 31.25 to 500 µg mL−1, with the root wood extract being the most potent. All tested fractions exhibited moderate activity on the test bacterial strains with MIC values of 250 µg mL−1.
The isolated compounds showed the best activity profile, with flindissone (3), ursolic acid (6) and 3-oxo, fridelin-28-ol (12) being the most potent with a broad spectrum activity (MIC varying from 4.09 to 71.8 µm). The Gram-negative E. coli ATCC 25922 appeared to be the most susceptible strain (MIC varying from 4.09 to 41.66 µm). The antibacterial activity displayed by the ethanolic crude extract from the root wood in this study was greater than that reported by Kuglerova et al. [33], who reported a weak antibacterial potency for the bark extract of T. prieuriana against Enterococcus faecalis and S. aureus (MIC of 512 and 256 µg mL−1 respectively). Data from the present study coupled with those previously reported by other researchers on plants from Meliaceae family such as Trichilia emetica [34], also indicated that limonoids, prieurianin (1), flindissone (3), deoxyflindissone (4) and picraquassin E (5) isolated from root wood extract could be responsible for the exhibited antibacterial activity. Indeed, the evaluated compounds showed inhibitory potential against three of the reference strains used. Isolated phytosterols such as β-sitosterol have been proven by many research groups to possess good antibacterial potential against several pathogenic bacteria including S. aureus [35, 36]. Extracts and compounds inhibited mostly Gram-negative compared to Gram-positive bacteria. This is not in accordance with the findings of other researchers who demonstrated that Gram-negative bacteria were more resistant to plant-based organic extracts because their hydrophilic cell wall structure is essentially constituted of lipopolysaccharides that block the penetration of hydrophobic oil thereby preventing the accumulation of organic extract in their cell membrane. However, the enhanced susceptibility of Gram-negative bacteria noticed in this work is of particular interest, given their significant impact in the global antimicrobial resistance outbreak. Indeed, in Gram-negative bacteria, intrinsic resistance to currently available antibiotics is mainly due to overexpressed efflux pumps which are constitutively present and also the presence of protective outer membrane that prevent drugs to reach their metabolic targets in effective doses.
3 Experimental section
3.1 General experimental procedures
IR spectra were recorded on a Bruker Fourier transform/infrared (ATR) spectrophotometer. Mass spectra (ESI-MS) were obtained with a Thermo-Finnigan LCQ DECA mass spectrometer and HR-ESI-MS spectra were measured with a FTHRMS-Orbitrap (Thermo-Finnigan) mass spectrometer. 1D and 2D-NMR spectra were recorded in deuterated solvents on either Bruker ARX 500 or AVANCE DMX 600 NMR spectrometers (proton at 600 MHz and carbon 13C at 150 MHz). All chemical shifts (δ) were measured in parts per million (ppm) using a residual solvent signal as secondary reference relatively to tetramethylsilane (TMS) as internal standard, while coupling constants (J) are given in Hz. Solvents were distilled prior to use. Analytical grade solvents were used for LC/MS. Column chromatography (CC) was performed using Merck MN silica gel 60 M (0.04–0.063 nm) and thin layer chromatography (TLC) was performed on aluminium silica gel 60 F254 (Merck) precoated plates (0.2 mm layer thickness). Spots were visualized on TLC either by UV lamp (254 and 365 nm) or by heating after spraying with 20% H2SO4 (v/v) solution. Different mixtures of n-hexane, EtOAc and MeOH were used as eluting solvents.
3.2 Plant material
Leaves, root wood, stem bark and root bark of T. prieuriana were collected in August 2016 at Mindourou (GPS coordinates: Latitude 3.98250 North and Longitude 14.89501 East), East region, Cameroon. Plant material was identified by Dr. Nole, plant taxonomist at the Institute of Medical Research and Medicinal Plants Studies (IMPM), Cameroon. Voucher specimens are preserved in the National Herbarium of Cameroon under the reference number 66990/HNC.
3.3 Extraction, fractionation and isolation
Dried ground leaves (2.3 kg), root wood (1.9 kg), stem bark (1.1 kg) and root bark (1.15 kg) of T. prieuriana were extracted three times with the mixture of ethanol–water (7:3) at room temperature for 48 h each time. The filtrate from each part was combined and evaporated to dryness to give 208 g of a green residue (leaves); 150 g, 387 and 44 g of a brown residues for root wood, stem bark and root bark respectively.
One hundred and 45 g of the hydro-ethanolic crude extract obtained from the root wood was subjected to flash chromatography over silica gel using a mixture of n-hexane and AcOEt of increasing polarity to afford four main fractions labelled F1 (20 g; n-hexane- EtOAc 4:1), F2 (10 g; n-hexane-EtOAc 1:1), F3 (15 g; pure EtOAc), and F4 (25 g; MeOH). Fraction F1 (20 g) was further chromatographed on a silica gel column and eluted with a mixture of n-hexane-EtOAc of increasing polarity. A total of 200 fractions, each of 175 mL, were collected and combined based on their TLC profiles to afford seven main subfractions [S1 (1–30), S2 (31–60), S3 (61–86), S4 (87–115), S5 (116–148), S6 (149–180) and S7 (181–200)]. Series S1, S2, S3, S4 and S5, after precipitation at room temperature, followed by filtration and washing with a mixture of n-hexane-EtOAc (1:1) yielded compounds 2 (30.09 mg), 3 (2 mg), 5 (30.68 mg), 15 (2056 mg) and 16 (25.23 mg), respectively. Fraction F2 (10 g) obtained by elution with n-hexane- EtOAc (1:1), was further purified over a silica gel column using a gradient of n-hexane-EtOAc to give a total 160 fractions of 100 mL each, which were further combined based on TLC profiles to afford nine main series [S1′ (1–15), S2′ (16–35), S3′ (35–48), S4′ (49–60), S5′ (60–80), S6′ (80–105), S7′ (106–120), S8′ (106–137), S9′ (138–160)]. Series S4′ and S6′ crystallized and after filtration, yielded compounds 1 (2.56 mg) and 4 (8.56 mg). Then S7′ was also crystallized at room temperature, and after filtration compounds 11 (20.67 mg) and 13 (25.33 mg) were obtained.
The crude extract from root wood (39.3 g) was chromatographed over silica gel column, eluting with n-hexane-EtOAc mixtures with increasing proportion of EtOAc. 200 mL fractions were collected, evaporated and pooled based on their profiles on the analytical TLC plate to give 15 main series [S1′ (1–11), S2′(12–39), S3′ (40–54), S4′ (55–106), S5′ (107–118), S6′ (119–156), S7′ (157–181), S8′ (182–211), S9′ (212–226), S10′ (227–314), S11′(315–348), S12′ (349–392), S13′ (393–433), S14′ (434–410), S15′ (511–539)]. Fractions 157 to 181, once combined and left at room temperature, precipitated to give, after filtration and washing, compound 15 (10.56 mg) as colourless powder. Similarly, fractions 315 to 348 eluted with n-hexane-EtOAc (1:1) afforded a pure compound 16 (10.76 mg) after evaporation of the solvent. Fractions 349 to 360, when combined and left at room temperature, precipitated in the form of colourless needles, to give compound 21 (8.89 mg), after filtration and washing with methanol. With a similar procedure, fractions 379–388 led to compound 22 (24.80 mg).
Crude extracts (376.44 g) from stem bark were subjected to flash chromatography over silica gel using n-hexane-EtOAc mixtures with increasing proportion of EtOAc gave five main fractions labelled F1 (58 g; n-hexane-EtOAc, 3 :1), F2 (11 g; n-hexane-EtOAc, 1:1), F3 (2 g n-hexane-EtOAc 1 :3), F4 (3 g; pure EtOAc), and F5 (23 g; MeOH).
Of 58 g obtained from fraction F1, 54 g were chromatographed over silica gel column (63–200 nm mesh particle size), eluting with n-hexane-EtOAc mixtures of increasing polarity. 240 sub-fractions of 175 mL each were collected and pooled into seven main sub-fractions (S1 [1–17], S2 [18–62], S3 [63–130], S4 [131–162], S5 [163–182], S6 [183–220] and S7 [221–240]), according to their TLC profiles. After precipitation, filtration and washing with methanol, sub-fractions 92–101 led to compound 7 (12.86 mg). The S6 series obtained by evaporation of the solvents from sub-fractions 183 to 220, were further subjected to chromatography over silica gel column and eluted iso cratically with the mixture of n-hexane-EtOAc (3:1). From the 40 sub-fractions collected, sub-fractions 20–28 yielded compound 6 (10.65 mg). Fraction F2 (11 g) obtained from the flash chromatography was chromatographed on a silica gel column (particle size of 63–200 nm mesh) and eluted with the n-hexane-EtOAc of increasing polarity. 245 sub-fractions of 200 mL each were collected and pooled into 10 sub-fractions (S1 [1–10], S2 [11–41], S3 [42–80], S4 [81–103], S5 [104–136], S6 [137–160], S7 [161–181], S8 [182–202], S9 [203–221] and S10 [222–245]), based on their analytical TLC profiles. Fractions 137–160 were combined after evaporation of the solvent to yield at room temperature, a green precipitate, which was further filtrated and washed with methanol to give compound 19 (10.04 mg). Sub-fractions 161–181 were left at room temperature for one day, and on crystallization with methanol gave compound 20 (12.04 mg) in the form of purple crystals.
Crude extract from leaves (182 g) were fractionated by flash chromatography over silica gel, eluting with n-hexane-EtOAc mixture of increasing polarity to give five fractions labelled F1 (25 g; n-hexane-EtOAc, 3:1), F2 (10 g; n-hexane-EtOAc, 1:1), F3 (9 g n-hexane-EtOAc 1:3), F4 (5 g; pure EtOAc), and F5 (15 g; MeOH).
Fraction F1 (20 g) was further chromatographed over silica gel column (63–200 nm mesh) and eluted with n-hexane-EtOAc mixtures of increasing polarity. 230 sub-fractions of 200 mL each were collected and grouped into 11 sub-fractions (S1 [1–10], S2 [11–55], S3 [56–86], S4 [87–116], S5 [117–134], S6 [135–155], S7 [156–171], S8 [172–182], S9 [183–204], S10 [205–211] and S11 [212–230]). From sub-fractions 82–86, when combined and left at room temperature, compound 3 (18.33 mg) precipitates as a colourless powder. Sub-fractions 183–204, when left at room temperature for a day, crystallized and yielded after filtration, a whitish-coloured powder, compound 6 (10.45 mg).
Fractions F2 (11 g) and F3 (2 g) were combined based on analytical TLC profiles. The resulting fraction was chromatographed over silica gel column (63–200 nm mesh) and eluted with the n-hexane-EtOAc mixture with increasing polarity of EtOAc. 260 sub-fractions of 200 mL each were collected and grouped into 9 main sub-fractions (S1 [1–31], S2 [32–55], S3 [56–86], S4 [87–117], S5 [118–141], S6 [142–168], S7 [169–200], S8 [201–240] and S9 [241–260]). Series S3 crystallized at room temperature to give compound 20 (10.05 mg) after filtration and washing with methanol. Similarly, series S5 after evaporation of the solvent gave a powder, which, when washed with ethyl acetate, resulted in compound 9 (14.42 mg). Series S7, (169–200) when left at room temperature for one day, precipitated as colourless powder to give compound 17 (8.67 mg). After evaporation of the solvent, from series S8, a precipitate was formed and it yielded compound 18 (9.48 mg) after washing with ethyl acetate. Sub-fractions 241–260 were left at room temperature for one day, and precipitated to give compound 13 (10.22 mg) as colourless powder.
3.4 Spectroscopic data of compounds 1 and 2
4.2-2β,3β,4β -trihydroxypregnan-16-one (1): Colourless crystals, m.p. 300–302 °C. – UV (MeOH): λ
max (log ɛ
max) = 218 nm (0.68), 230 (1.36). –
Prieurianin (2): Colourless crystals, m.p. 230–232 °C. –
3.5 X-ray crystal structure determinations
Single crystals of 1 and 2 were examined on a Rigaku Supernova diffractometer using CuKα radiation (λ = 1.54184 Å). The crystals were kept at T = 100.0(1) K during data collection. Using Olex2 [37], the structures were solved with Shelxt [38] using Intrinsic Phasing and refined with Shelxl [39] using least-squares minimisation.
Crystallographic data of 1 (C21H34O4, M = 350.48 g mol−1): orthorhombic, space group P212121 (no. 19), a = 7.69568(7) Å, b = 13.16355(15) Å, c = 18.2969(2) Å, V = 1853.52(3) Å3, Z = 4, μ(CuKα) = 0.675 mm−1, D calc = 1.256 g cm−3. 30994 measured reflections (8.3 ≤ 2θ ≤ 152.7°) 3869 of which were unique (R int = 0.0280, R σ = 0.0141) which were used in all further calculations. All hydrogen atoms were refined isotropically. The final R 1 was 0.0302 for 3770 reflections with I > 2σ(I) and 362 refined parameters, while wR 2 was 0.0890 for all data, Flack x = −0.06(5), Δρ fin (max/min) = 0.23/−0.14 e Å−3.
Crystal data of 2 (C38H50O16, M = 2.78 g mol−1): orthorhombic, space group P212121 (no. 19), a = 11.01447(10) Å, b = 11.78408(16) Å, c = 29.1402(3) Å, V = 3782.26(7) Å3, Z = 4, μ(CuKα) = 0.879 mm−1, D calc = 1.340 g cm−3, 66,605 measured reflections (6.1 ≤ 2θ ≤ 153.1°), 7886 of which unique (R int = 0.0266, R σ = 0.0126) which were used in all further calculations. Hydrogen atoms were refined using a riding model except donor hydrogen atoms, which were refined isotropically. The final R 1 was 0.0392 for 7813 reflections with I > 2σ(I) and 504 refined parameters, while wR 2 was 0.1163 for all data, Flack x = 0.04(3), Δρ fin (max/min) = 0.32/−0.19 e Å−3.
CCDC 2063671 and 2063672 contain the supplementary crystallographic data for 1 and 2. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/conts/retrieving.html.
3.6 Biological assays
3.6.1 Preparation of stock solution of plant extracts, fractions, compounds and amoxicillin
Stock solutions of plant extracts, fractions and compounds were prepared in dimethyl sulfoxide (DMSO) at 100 and 2 mg mL−1, respectively; while stock solution of amoxicillin tested as positive control was prepared at 2 mg mL−1 in sterile distilled water. The required drug concentrations were achieved through twofold six points dilution in Mueller Hinton Broth medium in 96-well microtiter plates and tested at 500, 250, 125, 62.5, 31.25, 15.625 and 7.8125 µg mL−1 for crude extracts; 250, 125, 62.5, 31.25, 15.625, 7.8125 and 3.90625 µg mL−1 for fractions and 71.8, 35.9, 17.95, 8.975, 4.4875 and 2.24375 µg mL−1 for isolated compounds. Amoxicillin was tested at concentrations ranging 1–128 µg mL−1.
3.6.2 Bacterial strains and culture conditions
The antibacterial activity of crude extracts, fractions and pure isolated compounds was evaluated against nine different pathogenic bacteria including six reference strains (S. pneumoniae ATCC 49619, E. coli ATCC 25922, S. flexneri NR 518, K. pneumoniae ATCC 700603, S. aureus ATCC 43300, S. aureus BAA 917) from the American Type Culture Collection, and three isolates (E. coli CHU, S. aureus CHU and S. enterica anatum) from the University Hospital, Yaoundé. Bacteria were continuously maintained in Mueller Hinton broth medium at the Antimicrobial and Biocontrol Agents Unit, University of Yaounde 1 at 37 °C and sub-cultured overnight prior to experiments.
3.6.3 Determination of the minimum inhibitory concentration (MIC)
The MIC values of extracts, fractions and isolated compounds was determined on the nine bacterial strains using the broth microdilution method as described by the M07-A9 protocol of CLSI [40]. Briefly, bacterial cells were collected in the logarithmic growth phase and diluted in Mueller Hinton broth to achieve 1.106 CFU mL−1. Aliquots of 100 µL of serial twofold dilutions of the test samples in Mueller Hinton broth were added to individual wells of a sterile 96-well microplate in triplicate. Then, 100 µL of the bacterial suspensions were added to each well to achieve an inoculum of approximate 5 × 105 CFU mL−1. The plate was incubated at 37 °C for 24 h. A blank column was included for sterility control. The concentrations of amoxicillin ranged from 1 to 128 µg mL−1. The MIC value was defined as the lowest concentration of inhibitor preventing visible growth of bacteria. All tests were performed in triplicate.
3.7 Statistical analysis
Antibacterial experiments were carried out in triplicate. Data were expressed as mean ± standard deviation from triplicate values. P values of 0.05 or less were considered statistically significant.
4 Conclusion
Crude extracts, fractions and pure isolated compounds from leaves, root wood, stem bark and root bark of T. prieuriana exhibited a broad-spectrum of antibacterial activity. The findings reported here provide a scientific rationale for the use of the hydroethanolic extracts of this plant in home-made remedies. However, before any validation of the eventual application of such extracts against infections by microorganisms such as S. pneumoniae, E. coli, S. flexneri, K. pneumoniae, S. aureus etc., further detailed pharmacological and toxicological studies are required. Upon completed of such studies, the promising extracts/fractions might eventually be formulated as phytomedicines as alternatives to the current antibacterial drugs. Moreover, further studies are also required for the isolated antibacterial natural products in a structure–activity–relationship perspective.
5 Supporting information
MS and NMR spectra for compounds 1 and 2 are given as supplementary material available online (https://doi.org/10.1515/znb-2021-0057).
Funding source: German Academic Exchange Service 10.13039/501100001654
Award Identifier / Grant number: 57316173
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: Authors are grateful to the German Academic Exchange Service (DAAD) for financial support to the Yaounde-Bielefeld Graduate School of Natural Products with Antiparasitic and Antibacterial activities (YaBiNaPA), project N° 57316173.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. Rai, J., Randhawa, G. K., Kaur, M. Int. J. Appl. Basic Med. Res. 2013, 3, 3–10; https://doi.org/10.4103/2141-9248.113670.Search in Google Scholar
2. Xie, Y. S., Isman, M. B., Gunning, P., MacKinnon, S., Arnason, J. T., Taylor, D. R., Sánchez, P., Hasbun, C., Towers, G. H. N. Biochem. Systemat. Ecol. 1994, 2, 129–136; https://doi.org/10.1016/0305-1978(94)90003-5.Search in Google Scholar
3. Pupo, M. T., Adorno, M. A. T., Vieira, P. C., Fernandes, J. B., das, G. F., da Silva, M. F., Pirani, J. R. J. Braz. Chem. Soc. 2000, 13, 382–388.10.1590/S0103-50532002000300014Search in Google Scholar
4. Vieira, I. J. C., Terra, W., da, S., Milena, D. S. T., Goncalves, M. D. S., Braz-Filho, R. Am. J. Anal. Chem. 2014, 5, 91–121; https://doi.org/10.4236/ajac.2014.52014.Search in Google Scholar
5. Tsamo, A. T., Pagna, J. I. M., Nangmo, P. K., Mkounga, P., Laatsch, H., Nkengfack, A. E. Z. Naturforsch. 2019, 74c, 175–182; https://doi.org/10.1515/znc-2018-0187.Search in Google Scholar
6. Tsamo, A. T., Mkounga, P., Njayou, F. N., Manutou, J., Kirk, M., Philip, G. H., Nkengfack, A. E. Chem. Pharm. Bull. 2013, 61, 1178–1183; https://doi.org/10.1248/cpb.c13-00506.Search in Google Scholar
7. Aladesanmi, A. J., Odediran, S. A. Fitoterapia 2000, 71, 179–182; https://doi.org/10.1016/s0367-326x(99)00143-4.Search in Google Scholar
8. Kemda, P. N., Akone, S. H., Tontsa, A. T., Zhen, L., Müller, W. E. G., Proksch, P., Nkengfack, A. E. Z. Naturforsch. 2017, 72b, 697–703; https://doi.org/10.1515/znb-2017-0058.Search in Google Scholar
9. Pupo, M. T., Vieira, P. C., Fernandes, J. B., Silva, M. F. G. F. Phytochemistry 1997, 45, 1495–1500; https://doi.org/10.1016/s0031-9422(97)00167-2.Search in Google Scholar
10. Tsamo, A. T., Nangmo, K. P., Mkounga, P., Müller, I. B., Marat, K., Sass, G., Nkengfack, A. E. Med. Chem. 2016, 12, 655–661.10.2174/1573406412666160106154357Search in Google Scholar PubMed
11. Nangmo, K. P., Tsamo, T. A., Zhen, L., Mkounga, P., Akone, S. H., Tsabang, N., Müller, W. E. G., Marat, K., Proksch, P., Nkengfack, A. E. Phytochem. Lett. 2018, 23, 120–126; https://doi.org/10.1016/j.phytol.2017.11.020.Search in Google Scholar
12. Ketwaru, P., Klass, J., Tinto, W. F., McLean, S., Reynolds, W. F. J. Nat. Prod. 1993, 56, 430–431; https://doi.org/10.1021/np50093a018.Search in Google Scholar
13. Gullo, V. P., Miura, I., Nakanishi, K., Cameron, A. F., Connolly, J. D., Duncanson, F. D., Harding, A. E., McGrindle, R., Taylor, D. A. H. J. Chem. Soc. Chem. Commun. 1975, 345–346; https://doi.org/10.1039/c39750000345.Search in Google Scholar
14. Liang, G.-Y., Alexander, I. G., Peter, G. W. Phytochemistry 1988, 27, 2283–2286; https://doi.org/10.1016/0031-9422(88)80143-2.Search in Google Scholar
15. Terra, W., da, S., Vieira, I. J. C., Braz-Filho, R., de Freitas, W. R., Kanashiro, M. M., Torres, M. C. M. Molecules 2013, 18, 12180–12191; https://doi.org/10.3390/molecules181012180.Search in Google Scholar
16. Jian, X., Di, X., Qing-Hua, L., Jing-Feng, H., Wen-Yuan, L., Ning, X., Feng, F., Wei, Q. J. Nat. Prod. 2016, 79, 1899–1910.10.1021/acs.jnatprod.6b00748Search in Google Scholar
17. Mahato, S. B., Kundu, A. P. Phytochemistry 1994, 37, 1517–1575; https://doi.org/10.1016/s0031-9422(00)89569-2.Search in Google Scholar
18. Kuo, Y. H., Chiang, Y. M. Chem. Pharm. Bull. 2000, 48, 593–596; https://doi.org/10.1248/cpb.48.593.Search in Google Scholar PubMed
19. Zhang, Q.-Y., Zhao, Y.-Y., Cheng, T.-M., Cui, Y.-X., Liu, X.-H. J. Asian Nat. Prod. Res. 2000, 2, 81–86; https://doi.org/10.1080/10286020008039896.Search in Google Scholar PubMed
20. Wu, Q. X., Su, Y. B., Zhu, Y. Fitoterapia 2011, 82, 493–496; https://doi.org/10.1016/j.fitote.2011.01.006.Search in Google Scholar PubMed
21. Akhisa, T., Yamamoto, K., Tamura, T., Kumura, Y., Iido, T., Nambara, T., Chang, F. C. Chem. Pharm. Bull. 1992, 40, 789–791.10.1248/cpb.40.789Search in Google Scholar
22. Mann, A., Ibrahim, K., Oyewale, A. O., Amupitan, J. O., Fatope, M. O., Okogun, J. I. Am. J. Chem. 2011, 1, 52–55.10.5923/j.chemistry.20110102.11Search in Google Scholar
23. Patra, A., Chaudhuri, S. K. Magn. Reson. Chem. 1987, 25, 95–100; https://doi.org/10.1002/mrc.1260250202.Search in Google Scholar
24. Pollier, J., Goossens, A. Phytochemistry 2012, 77, 10–15; https://doi.org/10.1016/j.phytochem.2011.12.022.Search in Google Scholar
25. Joshi, B. S., Singh, K. L., Raja, R. Magn. Reson. Chem. 1999, 37, 295–298; https://doi.org/10.1002/(sici)1097-458x(199904)37:4<295::aid-mrc457>3.0.co;2-z.10.1002/(SICI)1097-458X(199904)37:4<295::AID-MRC457>3.0.CO;2-ZSearch in Google Scholar
26. Pateh, U. U., Haruna, A. K., Garba, M., Iliya, I., Sule, I. M., Abubakar, M. S., Ambi, A. A. Niger. J. Pharm. Sci. 2009, 8, 19–25.Search in Google Scholar
27. Khatun, M., Billah, M., Quader, M. Dhaka Univ. J. Sci. 2012, 60, 5–10; https://doi.org/10.3329/dujs.v60i1.10327.Search in Google Scholar
28. Aktar, F., Abul, K. M., Hamidul, A. N. M., Hasanand, C. M., Rashid, M. A. J. Pharmacol. Sci. 2009, 8, 161–166.10.3329/dujps.v8i2.6031Search in Google Scholar
29. Akhmad, D., Soleh, K., Leonardus, B. S. K., Yana, M. S. J. Appl. Pharm. Sci. 2012, 2, 175–177.Search in Google Scholar
30. Prihantini, A. I., Tachibana, S., Itoh, K. Procedia Environ. Sci. 2015, 28, 758–768; https://doi.org/10.1016/j.proenv.2015.07.089.Search in Google Scholar
31. Jeremy, J., Bianca, J. D., Olivier, J. W., Paull, B., Bissember, C. A., Smith, J. A. Org. Lett. 2015, 17, 2428–2430.10.1021/acs.orglett.5b00936Search in Google Scholar
32. Kuete, V. Planta Med. 2010, 76, 1479–1491; https://doi.org/10.1055/s-0030-1250027.Search in Google Scholar
33. Kuglerova, M., Tesarova, H., Grade, J. T., Halamova, K., Maganyi, W. O., Damme, V. P., Kokoska, L. Afr. J. Biotechnol. 2011, 10, 3629–3632; https://doi.org/10.5897/ajb111107.Search in Google Scholar
34. Germanò, M. P., D'Angelo, V., Sanogo, R., Catania, S., Alma, R., De Pasquale, R., Bisignano, G. J. Ethnopharmacol. 2005, 96, 227–232; https://doi.org/10.1016/j.jep.2004.09.011.Search in Google Scholar
35. Lee, D. G., Lee, A. Y., Kim, S.-J., Jung, Y.-S., Lee, D.-H., Cho, E. J., Lee, S. Nat. Prod. Sci. 2014, 20, 107–112.Search in Google Scholar
36. Taleb-Contini, S. H., Salvador, M. J., Watanabe, E., Ito, I. Y., Oliveira, D. C. R. Braz. J. Pharm. Sci. 2003, 39, 403–408; https://doi.org/10.1590/s1516-93322003000400007.Search in Google Scholar
37. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
38. Sheldrick, G. M. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar
39. Sheldrick, G. M. Acta Crystallogr. 2015, C71, 3–8.Search in Google Scholar
40. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard-Ninth Edition M07-A9, Vol. 32, no. 2, 2012; p. 16.Search in Google Scholar
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/znb-2021-0057).
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- In this issue
- Research Articles
- Orthoamide und Iminiumsalze, CIV. Umsetzungen von Orthoamiden der Alkincarbonsäuren mit enolisierbaren Carbonylverbindungen – Cyclisierung der Kondensationsprodukte zu Pyran-Derivaten
- 1,3-Dimethyl-tetrakis(2-triphenylsilylethyl)dimethyldisiloxane: a new carbosilane for the preparation of high-refractive-index films
- Antibacterial activity of some chemical constituents from Trichilia prieuriana (Meliaceae)
- A cobalt-based coordination polymer with a tripodal carboxylate ligand: synthese, structure and properties
- The stannides Ca1.692Pt2Sn3.308, SrPtSn2 and EuAuSn2
- Synthesis and coordination chemistry of silver(I), gold(I) and gold(III) complexes with picoline-functionalized benzimidazolin-2-ylidene ligands
Articles in the same Issue
- Frontmatter
- In this issue
- Research Articles
- Orthoamide und Iminiumsalze, CIV. Umsetzungen von Orthoamiden der Alkincarbonsäuren mit enolisierbaren Carbonylverbindungen – Cyclisierung der Kondensationsprodukte zu Pyran-Derivaten
- 1,3-Dimethyl-tetrakis(2-triphenylsilylethyl)dimethyldisiloxane: a new carbosilane for the preparation of high-refractive-index films
- Antibacterial activity of some chemical constituents from Trichilia prieuriana (Meliaceae)
- A cobalt-based coordination polymer with a tripodal carboxylate ligand: synthese, structure and properties
- The stannides Ca1.692Pt2Sn3.308, SrPtSn2 and EuAuSn2
- Synthesis and coordination chemistry of silver(I), gold(I) and gold(III) complexes with picoline-functionalized benzimidazolin-2-ylidene ligands